Jim Cramer Says Investors Shouldn't Sell Pfizer Stock After Earnings

Pfizer's  (PFE) - Get Report  quarterly earnings beat expectations, and TheStreet's Jim Cramer says investors shouldn't sell the stock. The company's profits fell, but it did report higher sales. Cramer notes Pfizer's stock ran a lot after the Allergan  (AGN) - Get Report deal broke up, but he still likes it.